| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $15,654,801 ) (Continued on the next page) |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA283323 | Development of Best-in-Class Pol-Theta Inhibitors | 000 | 2 | NIH | 3/20/2025 | $613,937 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI152251 | Oligodendrocyte extracellular vesicles: a novel therapy for CNS autoimmunity | 000 | 5 | NIH | 2/13/2025 | $378,300 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA236857 | Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer | 000 | 7 | NIH | 1/17/2025 | $288,417 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA236857 | Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer | 002 | 7 | NIH | 1/24/2025 | $13,539 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AR076941 | Plasma-based therapies for bone infection: A tripartite USA/Northern Ireland/Republic of Ireland consortium | 000 | 5 | NIH | 12/11/2024 | $592,145 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R35GM156496 | Biogenesis and function of cyclic phosphate-containing RNAs | 000 | 1 | NIH | 2/3/2025 | $429,000 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI149795 | Pan-lyssavirus therapeutics and mechanisms of protection against lyssaviruses | 000 | 5 | NIH | 12/11/2024 | $378,300 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R03AG088868 | Novel Therapeutic Strategies for Suppressing cGAS-STING Pathway in Alzheimer's Disease | 000 | 1 | NIH | 12/12/2024 | $156,000 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA279364 | A Next-Generation Nucleoside Prodrug for Diffuse Large B-Cell Lymphoma | 000 | 2 | NIH | 11/8/2024 | $561,238 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01NS112504 | Investigating the Role and Regulation of the MAP7 Family Proteins in Axonal Morphogenesis and Function | 000 | 5 | NIH | 11/27/2024 | $385,296 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA236857 | Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer | 001 | 7 | NIH | 1/23/2025 | $27,852 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R35GM156956 | Elucidating the mechanisms underlying DNA double-strand break repair | 000 | 1 | NIH | 1/23/2025 | $390,000 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R37CA234239 | Tumor Microenvironment Metabolism in Invasive Ductal Carcinoma of the Breast | 000 | 6 | NIH | 1/9/2025 | $321,167 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R35GM152198 | Novel Mechanisms and Regulation of Mammalian Double-Strand Break Repair | 001 | 2 | NIH | 1/8/2025 | $667,775 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA268899 | A novel strategy for transcriptional reprogramming of lymphoid leukemia cells | 000 | 4 | NIH | 1/9/2025 | $486,021 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AR082460 | The role of endogenous low molecular weight mineralization inhibitors in spine health | 000 | 2 | NIH | 11/13/2024 | $599,407 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21AG091424 | The Role of Alzheimer's Disease Risk Genes in Neural Function, Degeneration, and Synapse Organization | 000 | 1 | NIH | 1/15/2025 | $429,000 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21AI190614 | The Role of the GPR15-C10ORF99 Pathway in T cell Homing during Eosinophilic Esophagitis | 000 | 1 | NIH | 2/1/2025 | $226,980 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01MH138995 | Pathophysiologic roles of protein-protein interactions at excitatory synapses and their modifications in schizophrenia | 000 | 1 | NIH | 11/29/2024 | $706,404 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA244522 | Tissue Damage-Driven Squamous Cell Carcinoma | 000 | 5 | NIH | 1/1/2025 | $321,165 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21CA286339 | Ligand-Induced Recruitment of CAR-T Cells to Colorectal Cancers | 000 | 2 | NIH | 11/26/2024 | $164,093 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HD112076 | Dose based aspirin pharmacokinetics and pharmacodynamics in pregnancy and association with pregnancy outcomes | 000 | 1 | NIH | 1/13/2025 | $678,809 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI156384 | Role of IL-7R in CNS autoimmunity | 000 | 4 | NIH | 11/26/2024 | $378,300 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL140064 | Biased Muscarinic Acetylcholine Receptor Signaling in Obstructive Lung Disease Pathology and Therapy | 000 | 6 | NIH | 1/13/2025 | $595,123 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01ES033197 | METTL3 in chromium-induced angiogenesis and carcinogenesis | 000 | 4 | NIH | 1/14/2025 | $519,475 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA236853 | BCLW in lymphoma survival and resistance to targeted BCL2 family therapies | 000 | 6 | NIH | 11/25/2024 | $327,764 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R00AG066938 | Molecular mechanisms of Werner syndrome helicase in genome stability and aging | 000 | 5 | NIH | 12/16/2024 | $224,100 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA269750 | Multi-modality detection of RCC Recurrence Post Ablation | 000 | 3 | NIH | 11/15/2024 | $530,756 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | F30NS130973 | Determining the cellular and nanoscale localization of Synaptotagmin VII | 000 | 3 | NIH | 11/19/2024 | $53,974 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R03AI187994 | Regulation of cytoskeletal reorganization by a single effector during Chlamydia infection | 000 | 1 | NIH | 11/18/2024 | $75,660 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01GM144553 | Crosstalk between DNA repair pathways in repeat instability | 000 | 3 | NIH | 12/9/2024 | $280,800 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL122124 | Mitochondria-SR Tethering: Its Role in Cardiac Bioenergetics and Ca2+ Dynamics | 000 | 8 | NIH | 11/21/2024 | $492,718 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AG078609 | Promoting regenerative repair of aged cartilage | 000 | 3 | NIH | 1/17/2025 | $646,492 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21NS135762 | Molecular pathways linking frontotemporal dementia and circadian dysfunction | 000 | 2 | NIH | 2/14/2025 | $195,000 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL173113 | Allosteric modulation of beta2- adrenoceptors in the treatment of asthma | 000 | 2 | NIH | 3/25/2025 | $509,870 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DK138011 | Relevance of fatty acid handling in the adaptive response to mitochondrial dysfunction | 000 | 2 | NIH | 2/17/2025 | $473,105 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA263506 | MiR-152/PKM2/SLC7A5 axis in breast cancer development, chemo- and radiation-treatment response | 000 | 4 | NIH | 3/27/2025 | $580,329 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DK136992 | Hypercalciuria and Abnormal Bone in the Genetic Hypercalciuric Stone-Forming Rats | 000 | 2 | NIH | 3/27/2025 | $410,872 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DK125897 | ER-mitochondrial communication in calcium signaling, energy metabolism and liver disease | 000 | 5 | NIH | 2/20/2025 | $429,469 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI181264 | Regulation of homotypic fusion by Chlamydia | 000 | 2 | NIH | 12/19/2024 | $533,307 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA262570 | Pharmacological Jak2 inhibition to overcome androgen receptor aberrations in prostate cancer | 002 | 4 | NIH | 3/19/2025 | $537,456 |
| | 2025 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | CPIMP221350 | ROLE: Reducing Risk for Readmission, Optimizing Language Access and Improving Equity | 01 | 3 | DHHS/OS | 1/17/2025 | $0 |
| | 2025 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R35GM131832 | Molecular Mechanisms of Mitochondrial Transcription and Replication | 000 | 6 | NIH | 11/7/2024 | $0 |
| | 2025 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R35GM134931 | tRNA in codon usage | 000 | 5 | NIH | 11/8/2024 | $0 |
| | 2025 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL058506 | G Protein-Coupled Receptor Regulation in Airway Myocytes | 000 | 25 | NIH | 10/29/2024 | $0 |
| | 2025 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R35GM152198 | Novel Mechanisms and Regulation of Mammalian Double-Strand Break Repair | 000 | 1 | NIH | 11/5/2024 | $0 |
| | 2025 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | T32GM008562 | Clinical Pharmacology Training Program | 000 | 30 | NIH | 10/29/2024 | $0 |
| | 2025 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | T32GM008562 | Clinical Pharmacology Training Program | 000 | 30 | NIH | 10/29/2024 | $0 |
| | 2025 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | T5C52049 | Primary Care Training and Enhancement - Language and Disability Access | 03 | 2 | HRSA | 12/9/2024 | $0 |
|
